Overview

Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea

Status:
Recruiting

Trial end date:
2024-04-01

Target enrollment:

Participant gender:

Summary

The addition of intranasal oxymetazoline for two weeks to already instituted optimal doses of intranasal fluticasone propionate will decrease the total number of obstructive apneas and hypopneas per hour of sleep in subjects with perennial allergic or non-allergic rhinitis and mild obstructive sleep apnea who have persistent nasal congestion despite maximum doses of NGCS.

Phase:

Phase 4

Details

Lead Sponsor:

University of South Florida

Treatments:

Fluticasone
Oxymetazoline
Phenylephrine